Sources | Names Used |
---|---|
CTRPv2 | navitoclax:sorafenib (1:1 mol/mol) |
PharmacoGx | navitoclax:sorafenib (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-20 |
mRNA | TUBA1A | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-14 |
mRNA | RP11-729L2.2 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-14 |
mRNA | SMAD4 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |
mRNA | GOLGA8M | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-14 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-14 |
mRNA | HDHD2 | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-14 |
mRNA | TIFAB | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-14 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.3 | 9e-14 |